Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary

Eurofins Genomics (Ebersberg, Germany) has acquired VBC-Biotech's (Vienna, Austria) oligonucleotide synthesis and DNA sequencing businesses, and an Austrian subsidiary is being established.

Eurofins MWG Operon is an international provider of genomic services established around the core business lines next generation sequencing (NGS), custom DNA sequencing, oligonucleotides, siRNA, and gene synthesis. A team of experts and a broad range of technologies in the field of genomic services, forensics, agroscience, pharmaceutical, environmental, food and feed testing, underline the approach to offer best praxis solutions and versatile concepts.

Eurofins Genomics is the genomics division of the Eurofins Scientific Group. The Austrian subsidiary called Eurofins Genomics AT and headquartered in Vienna, will leverage Eurofins' global network, production capacity, and infrastructure. "The new direct presence in Austria will provide value to our customers by demonstration our commitment to this market," Eurofins Genomics AT Managing Director Siegfried Schnabl said in a statement. "Furthermore, Vienna will serve as a perfect hub for future business into Central and Eastern Europe and beyond."

The joint company is located in Vienna. All VBC-Biotech's services have been integrated into the Eurofins Genomics business units.

Financial and other terms of the deal were not disclosed.

Related Links:
Eurofins Genomics
VBC-Biotech's